Cypress Capital’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.09M | Sell |
26,389
-34
| -0.1% | -$2.69K | 0.61% | 41 |
|
2025
Q1 | $2.37M | Buy |
26,423
+1,144
| +5% | +$103K | 0.68% | 31 |
|
2024
Q4 | $2.51M | Buy |
25,279
+272
| +1% | +$27.1K | 0.72% | 27 |
|
2024
Q3 | $2.84M | Buy |
25,007
+528
| +2% | +$60K | 0.73% | 24 |
|
2024
Q2 | $3.03M | Sell |
24,479
-192
| -0.8% | -$23.8K | 0.76% | 17 |
|
2024
Q1 | $3.26M | Sell |
24,671
-103
| -0.4% | -$13.6K | 0.89% | 17 |
|
2023
Q4 | $2.7M | Buy |
24,774
+137
| +0.6% | +$14.9K | 0.77% | 23 |
|
2023
Q3 | $2.54M | Sell |
24,637
-1,096
| -4% | -$113K | 0.74% | 20 |
|
2023
Q2 | $2.97M | Buy |
25,733
+298
| +1% | +$34.4K | 0.85% | 14 |
|
2023
Q1 | $2.71M | Buy |
25,435
+362
| +1% | +$38.5K | 0.85% | 13 |
|
2022
Q4 | $2.78M | Buy |
25,073
+41
| +0.2% | +$4.55K | 0.87% | 13 |
|
2022
Q3 | $2.16M | Buy |
25,032
+725
| +3% | +$62.4K | 0.76% | 22 |
|
2022
Q2 | $2.22M | Buy |
24,307
+424
| +2% | +$38.7K | 0.32% | 52 |
|
2022
Q1 | $1.96M | Sell |
23,883
-553
| -2% | -$45.4K | 0.24% | 70 |
|
2021
Q4 | $1.87M | Buy |
24,436
+1,781
| +8% | +$136K | 0.21% | 77 |
|
2021
Q3 | $1.7M | Buy |
22,655
+4,434
| +24% | +$333K | 0.22% | 72 |
|
2021
Q2 | $1.42M | Buy |
18,221
+2,461
| +16% | +$191K | 1.38% | 37 |
|
2021
Q1 | $1.16M | Buy |
15,760
+1,538
| +11% | +$113K | 0.47% | 52 |
|
2020
Q4 | $1.11M | Sell |
14,222
-14
| -0.1% | -$1.09K | 0.5% | 42 |
|
2020
Q3 | $1.09M | Sell |
14,236
-1,075
| -7% | -$82.6K | 0.51% | 42 |
|
2020
Q2 | $1.13M | Buy |
+15,311
| New | +$1.13M | 0.5% | 31 |
|
2019
Q4 | $986K | Buy |
11,367
+413
| +4% | +$35.8K | 0.41% | 31 |
|
2019
Q3 | $880K | Buy |
10,954
+565
| +5% | +$45.4K | 0.4% | 36 |
|
2019
Q2 | $831K | Buy |
+10,389
| New | +$831K | 0.38% | 34 |
|